These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23468295)

  • 1. Andrew Witty: the acceptable face of big pharma? Interviewed by Rebecca Coombes.
    Witty A
    BMJ; 2013 Mar; 346():f1458. PubMed ID: 23468295
    [No Abstract]   [Full Text] [Related]  

  • 2. Big pharma under the spotlight.
    Farham B
    S Afr Med J; 2013 May; 103(6):352. PubMed ID: 23725968
    [No Abstract]   [Full Text] [Related]  

  • 3. Only time will tell whether big pharma has an acceptable face.
    Jundi O
    BMJ; 2013 Apr; 346():f1952. PubMed ID: 23550071
    [No Abstract]   [Full Text] [Related]  

  • 4. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharma goes to the laundry: Public relations and the business of medical education.
    Elliott C
    Hastings Cent Rep; 2004; 34(5):18-23. PubMed ID: 15553394
    [No Abstract]   [Full Text] [Related]  

  • 6. Risky business.
    Ment Health Today; 2005 May; ():12-3. PubMed ID: 15938578
    [No Abstract]   [Full Text] [Related]  

  • 7. Patrick J. Zenner.
    Zenner PJ
    N J Med; 2000 Aug; 97(8):20-7. PubMed ID: 10959172
    [No Abstract]   [Full Text] [Related]  

  • 8. NICE is urged to make drug companies supply all trial data.
    O'Dowd A
    BMJ; 2012 Dec; 345():e8294. PubMed ID: 23223692
    [No Abstract]   [Full Text] [Related]  

  • 9. The dominance of big pharma: power.
    Edgar A
    Med Health Care Philos; 2013 May; 16(2):295-304. PubMed ID: 22331475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good pharma? Bad pharma? Better pharma.
    Hardman M
    J R Coll Physicians Edinb; 2014; 44(4):269-72. PubMed ID: 25516893
    [No Abstract]   [Full Text] [Related]  

  • 11. The dominance of Big Pharma: unhealthy relationships?
    Badcott D; Sahm S
    Med Health Care Philos; 2013 May; 16(2):245-7. PubMed ID: 22351151
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug companies should release data from all trials of licensed drugs, say MPs.
    Hawkes N
    BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
    [No Abstract]   [Full Text] [Related]  

  • 13. Good pharma, bad pharma.
    Drug Ther Bull; 2013 Aug; 51(8):85. PubMed ID: 23927857
    [No Abstract]   [Full Text] [Related]  

  • 14. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 15. On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin.
    Abraham J
    Soc Sci Med; 2010 Mar; 70(5):648-51. PubMed ID: 20056525
    [No Abstract]   [Full Text] [Related]  

  • 16. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

  • 17. Bashing Big Pharma.
    Van Way CW
    Mo Med; 2019; 116(2):80-82. PubMed ID: 31040484
    [No Abstract]   [Full Text] [Related]  

  • 18. How a marriage with big pharma ended in divorce.
    Arie S
    BMJ; 2013 Oct; 347():f6062. PubMed ID: 24103763
    [No Abstract]   [Full Text] [Related]  

  • 19. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 20. Only one handed applause due.
    Griffith D
    BMJ; 2013 Apr; 346():f1954. PubMed ID: 23550072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.